Tissue Engineering Part C-Methods

Scope & Guideline

Pioneering Innovative Approaches in Bioengineering

Introduction

Immerse yourself in the scholarly insights of Tissue Engineering Part C-Methods with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1937-3384
PublisherMARY ANN LIEBERT, INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2008 to 2024
AbbreviationTISSUE ENG PART C-ME / Tissue Eng. Part C-Methods
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801

Aims and Scopes

Tissue Engineering Part C-Methods is dedicated to advancing the field of tissue engineering through innovative methodologies, experimental techniques, and practical applications. The journal emphasizes translational research that bridges the gap between laboratory findings and clinical applications. Here are the core areas of focus:
  1. Tissue Engineering Methodologies:
    The journal covers a broad range of methodologies for tissue engineering, including scaffold development, cell culture techniques, and bioreactor systems, focusing on how these techniques can be optimized for better tissue regeneration.
  2. Biomaterials Development:
    Research on various biomaterials, including natural and synthetic polymers, hydrogels, and bioactive glass, is a significant focus. The journal explores how these materials can enhance cell adhesion, proliferation, and differentiation.
  3. Stem Cell Applications:
    The use of stem cells in tissue engineering is a prominent theme, with studies investigating their differentiation pathways and the impact of various scaffolds and growth factors on their regenerative potential.
  4. In Vitro and In Vivo Models:
    The journal emphasizes the development and validation of in vitro and in vivo models for studying tissue engineering applications, critical for assessing the efficacy and safety of engineered tissues.
  5. Immunomodulation in Tissue Engineering:
    Research on how the immune response affects tissue regeneration is increasingly relevant, with studies focusing on techniques to modulate immune responses to improve graft acceptance and functionality.
The journal has seen a rise in interest in several emerging themes that reflect the evolving landscape of tissue engineering and regenerative medicine. These trends indicate areas of significant growth and potential future impact:
  1. 3D Bioprinting Techniques:
    There is a growing trend towards the use of 3D bioprinting technologies for creating complex tissue structures, allowing for precise control over scaffold architecture and cellular organization.
  2. Extracellular Vesicles and Cell Secretome Studies:
    Research focusing on the role of extracellular vesicles and the secretome from various cell types is gaining momentum, highlighting their potential in regenerative therapies and as biomarkers.
  3. Personalized Medicine Approaches:
    The journal is increasingly publishing studies that emphasize personalized medicine, particularly in the context of using patient-derived cells and tailored scaffolds for tissue regeneration.
  4. Integration of AI and Machine Learning:
    The incorporation of artificial intelligence and machine learning techniques into tissue engineering research is on the rise, particularly in optimizing scaffold designs and predicting cell behavior.
  5. Immunomodulatory Biomaterials:
    The development and study of biomaterials that can actively modulate the immune response to enhance tissue integration and regeneration are emerging as a significant area of interest.

Declining or Waning

While Tissue Engineering Part C-Methods continues to thrive in various areas, certain themes have shown a decline in publication frequency. These waning scopes indicate shifts in research focus and methodologies over the years:
  1. Traditional 2D Cell Culture Models:
    There has been a noticeable decline in the publication of studies utilizing traditional 2D cell culture models, as researchers increasingly adopt more advanced 3D culture techniques that better mimic the in vivo environment.
  2. Basic Biomaterial Characterization:
    Research solely focused on the basic characterization of biomaterials without application to specific tissue engineering challenges is becoming less common, as the field moves towards more applied research that addresses clinical needs.
  3. Animal Models with Limited Clinical Relevance:
    Studies involving animal models that do not translate well into human applications are decreasing, with a shift towards models that better represent human physiology and disease states.
  4. Non-Functionalized Biomaterials:
    The exploration of non-functionalized biomaterials is diminishing as the focus shifts towards biofunctionalization strategies that enhance interaction with biological systems and improve regenerative outcomes.

Similar Journals

Materials Today Bio

Unlocking innovative solutions at the intersection of materials and biology.
Publisher: ELSEVIERISSN: 2590-0064Frequency: 4 issues/year

Materials Today Bio, published by Elsevier, is an esteemed open-access journal dedicated to advancing the fields of bioengineering, biomaterials, and biomedical engineering. Since its inception in 2019, this journal has quickly made a name for itself, currently ranked Q1 in multiple categories including Bioengineering, Biomaterials, and Biotechnology, reflecting its exceptional quality and relevance in the rapidly evolving landscape of bio-related sciences. With an impressive Scopus ranking positioning it in the top 25% of its categories, Materials Today Bio provides a vital platform for researchers and professionals to share cutting-edge discoveries and innovative applications that bridge the gap between materials science and biological studies. Accessible to a global audience, this journal not only fosters collaboration among the scientific community but also aims to highlight significant advancements in cell and molecular biology, making it an indispensable resource for students and seasoned experts alike. The journal's commitment to open access since 2019 underscores its dedication to disseminating knowledge widely, ensuring that crucial findings reach those who can benefit from them the most.

Current Stem Cell Research & Therapy

Advancing the Frontiers of Stem Cell Science
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1574-888XFrequency: 8 issues/year

Current Stem Cell Research & Therapy, published by Bentham Science Publishers Ltd, is a leading journal dedicated to advancing the field of stem cell research. With an ISSN of 1574-888X and an E-ISSN of 2212-3946, this journal has been a valuable resource since its inception in 2006 and continues to broaden its scope through 2024. Recognized in the Q2 quartile for Medicine (miscellaneous) and ranked in the 66th percentile among its peers, the journal plays a crucial role in disseminating high-quality, peer-reviewed research that explores both the therapeutic and biological implications of stem cells. Located in the United Arab Emirates, Current Stem Cell Research & Therapy embraces a global audience of researchers, professionals, and students, providing a vibrant platform for discourse and innovation. While the journal offers subscription-based access, it remains committed to enhancing the scientific community's understanding of stem cell therapy and its applications across various medical fields.

Journal of Tissue Engineering

Exploring Innovations in Biomaterials and Beyond
Publisher: SAGE PUBLICATIONS INCISSN: 2041-7314Frequency: 1 issue/year

The Journal of Tissue Engineering, published by SAGE Publications Inc., stands at the forefront of innovation in the interdisciplinary fields of biomaterials and biomedical engineering. Established as an open access journal since 2010, it has quickly ascended to a leading position, as evidenced by its impressive rankings in 2023: Q1 in Biomaterials, Q1 in Biomedical Engineering, and Q1 in Medicine (miscellaneous). With a current impact factor that underscores its academic influence, this journal provides a vital platform for researchers, professionals, and students to share groundbreaking discoveries and advancements in tissue engineering and regenerative medicine. Located in the United Kingdom, the journal fosters a global dialogue with its robust publications and rigorous peer-review process, contributing significantly to the enhancement and understanding of complex biological systems. Join the esteemed community of thought leaders and innovators shaping the future of healthcare through the Journal of Tissue Engineering.

CELLS TISSUES ORGANS

Unlocking the Secrets of Anatomy and Histology.
Publisher: KARGERISSN: 1422-6405Frequency: 6 issues/year

CELLS TISSUES ORGANS is a renowned academic journal published by KARGER, focusing on pivotal research within the fields of Anatomy and Histology. Based in Switzerland, this journal has been disseminating influential scientific findings since 1889, contributing to our understanding of cellular structures and tissue functionality. With a current impact factor that places it in the Q2 quartile for both disciplines, it serves as a vital resource for researchers, professionals, and students seeking to stay abreast of significant advancements and discussions in these areas. The journal embraces an Open Access model, ensuring that high-quality, peer-reviewed articles are freely available, thus enhancing visibility and accessibility of critical research. As it continues to foster scholarly communication and innovation up to 2024, CELLS TISSUES ORGANS plays a crucial role in shaping the future of biological sciences and medical research.

ACS Biomaterials Science & Engineering

Advancing the Future of Biomaterials and Biomedical Engineering
Publisher: AMER CHEMICAL SOCISSN: 2373-9878Frequency: 12 issues/year

ACS Biomaterials Science & Engineering, published by the American Chemical Society, serves as a premier platform for the latest advancements and research in the fields of biomaterials and biomedical engineering. With an impressive impact factor and a strong reputation reflected in its ranking—Q2 in Biomaterials and Q1 in Biomedical Engineering—the journal attracts a diverse and engaged readership. Since its inception in 2015, it has aimed to foster innovation by publishing high-quality research articles, reviews, and perspectives on the synthesis, characterization, and application of biomaterials. Researchers and professionals benefit from the journal's rigorous peer-review process and its focus on translational science, making it essential for those looking to stay at the forefront of biomaterials research. Located in Washington, DC, USA, the journal plays a pivotal role in connecting academic and industrial sectors, ultimately driving advancements that impact biomedicine and related fields.

Regenerative Medicine

Charting New Territories in Regenerative Medicine
Publisher: TAYLOR & FRANCIS LTDISSN: 1746-0751Frequency: 12 issues/year

Regenerative Medicine, published by Taylor & Francis Ltd, is a pivotal journal within the field of biomedical research, focusing on the innovative advances in regenerative and restored functions in human health. With an ISSN of 1746-0751 and an E-ISSN of 1746-076X, this esteemed journal boasts a commendable impact factor within its categories, notably holding the Q2 status in Embryology and Q3 in Biomedical Engineering as of 2023. Covering a broad spectrum of topics from stem cell research to tissue engineering, it serves as a crucial platform for interdisciplinary collaboration among researchers, professionals, and students dedicated to the regeneration of tissues and organs. Given its comprehensive scope from 2006 to 2024, the journal continues to attract high-quality manuscripts that advance the frontiers of knowledge in regenerative medicine. Researchers and practitioners alike are encouraged to engage with the latest findings and methodologies disseminated in this vital publication.

Regenerative Biomaterials

Bridging Science and Application in Biomaterials
Publisher: OXFORD UNIV PRESSISSN: 2056-3418Frequency: 1 issue/year

Regenerative Biomaterials, published by Oxford University Press, serves as a premier platform for the dissemination of innovative research in the rapidly evolving field of biomaterials. Since its inception in 2014, this esteemed open-access journal has fostered a collaborative and diverse scientific community, providing free access to impactful articles that enhance our understanding of regenerative medicine and tissue engineering. With a commendable impact factor and ranking within the top quartiles of both Biomedical Engineering and Materials Science, it is recognized for its rigorous peer-review process and high-quality publications. The journal aims to bridge the gap between fundamental research and applied sciences, promoting advanced studies that contribute to clinical applications and regeneration strategies. Researchers, practitioners, and students alike are encouraged to engage with the journal’s content to foster interdisciplinary collaboration and drive future innovations in the biomaterials domain.

CELL AND TISSUE BANKING

Exploring the frontiers of biomedical engineering.
Publisher: SPRINGERISSN: 1389-9333Frequency: 4 issues/year

CELL AND TISSUE BANKING, published by Springer, is a prominent journal dedicated to advancing the fields of biomaterials, biomedical engineering, cell biology, and transplantation. With its ISSN 1389-9333 and E-ISSN 1573-6814, the journal plays a crucial role in disseminating high-quality research from its inception in 2000 to its ongoing contributions through 2024. Situated in the Netherlands, it boasts a respectable 2023 impact factor with notable quartile rankings, positioning it within the Q3 category for biomaterials, biomedical engineering, and transplantation, and Q4 for cell biology. Furthermore, its Scopus rankings underscore its relevance and influence, particularly in the fields of medicine and engineering. Although it does not currently offer open access options, the journal remains a vital resource for researchers, professionals, and students alike, fostering innovation and knowledge transfer in the critical areas of cell and tissue sustainability.

Journal of Biological Engineering

Elevating Interdisciplinary Collaboration in Biological Sciences
Publisher: BMCISSN: 1754-1611Frequency: 1 issue/year

Journal of Biological Engineering, published by BMC, stands as a prominent Open Access journal since 2007, dedicated to advancing the interdisciplinary field of biological engineering. With an ISSN of 1754-1611, this UK-based journal aims to provide a platform for researchers and professionals to disseminate innovative and impactful research across various domains including Biomedical Engineering, Environmental Engineering, Cell Biology, and Molecular Biology. The journal's notable rankings in the 2023 category quartiles exemplify its position within the scientific community, featuring Q2 status in Biomedical Engineering and Environmental Engineering, along with Q3 in Cell Biology and Q2 in Molecular Biology. By maintaining robust Scopus rankings and ensuring free access to cutting-edge research, the Journal of Biological Engineering plays a crucial role in driving discovery and collaboration among scholars, thereby enriching both the academic landscape and applied sciences.

Organogenesis

Unveiling the Complexities of Organogenesis.
Publisher: TAYLOR & FRANCIS INCISSN: 1547-6278Frequency: 4 issues/year

Organogenesis is a leading journal published by Taylor & Francis Inc, dedicated to advancing the field of developmental biology and regenerative medicine. With an ISSN of 1547-6278 and E-ISSN 1555-8592, this journal spans an extensive research scope that includes embryology, transplantation, and biomedical engineering, distinguishing itself as a crucial platform for researchers and practitioners alike. Its impact is reflected in its performance across various categories in 2023, earning Q3 rankings in Biomedical Engineering and Embryology, Q4 in Developmental Biology, and Q2 in Transplantation, showcasing its reputable standing among peer journals. Moreover, with Scopus rankings indicating strong positioning in the fields of medicine and biochemistry, Organogenesis is essential for those looking to publish or stay updated on pioneering research. The journal facilitates rigorous peer-review and offers a forum for disseminating innovative findings, making it an invaluable resource for academics, professionals, and students committed to understanding the complexities of organism development.